Overview
Giorgia Santilli practices in London, United Kingdom. Ms. Santilli is rated as a Distinguished expert by MediFind in the treatment of Leukocyte Adhesion Deficiency Type 1. Her top areas of expertise are Chronic Granulomatous Disease, Leukocyte Adhesion Deficiency Type 1, Wiskott-Aldrich Syndrome, and X-Linked Agammaglobulinemia.
Her clinical research consists of co-authoring 39 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Leukocyte Adhesion Deficiency Type 1.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Granulomatous DiseaseMs. Santilli isElite. Learn about Chronic Granulomatous Disease.
- Distinguished
- Leukocyte Adhesion Deficiency Type 1Ms. Santilli isDistinguished. Learn about Leukocyte Adhesion Deficiency Type 1.
- Experienced
- Blood ClotsMs. Santilli isExperienced. Learn about Blood Clots.
- Embryonal Tumor with Multilayered RosettesMs. Santilli isExperienced. Learn about Embryonal Tumor with Multilayered Rosettes.
- Infantile NeutropeniaMs. Santilli isExperienced. Learn about Infantile Neutropenia.
- NeuroblastomaMs. Santilli isExperienced. Learn about Neuroblastoma.
- Pompe DiseaseMs. Santilli isExperienced. Learn about Pompe Disease.
- Primary Immunodeficiency (PID)Ms. Santilli isExperienced. Learn about Primary Immunodeficiency (PID).